Description

Functionally profiling compounds in disease-relevant tumor cell models to support mechanism-of-action studies, lead optimization, and translational decision-making.

We offer tumor cell profiling services using biologically relevant cancer cell models to evaluate compound activity, pathway modulation, and phenotypic responses. Our approach goes beyond simple viability measurements, focusing on functional and mechanistic insights that inform early discovery and lead optimization.

By integrating well-characterized tumor cell lines with customized assay formats, we help clients generate actionable data that better reflects tumor biology and therapeutic context.

From single-point screening to full dose–response characterization, our experienced scientists work closely with clients to ensure assays are tailored to specific targets, pathways, and project goals.

What We offer

• Tumor cell–based functional assaysProliferation, apoptosis, signaling pathway modulation, and phenotypic responses

• Pathway-focused profilingEvaluation of oncogenic signaling, stress response, and target-specific pathways

• Dose–response and potency assessmentEC₅₀ / IC₅₀ determination across tumor cell models

• Comparative profiling across cell panelsAssessing differential responses across tumor types or genetic backgrounds

• Assay-ready tumor modelsOptimized cell systems compatible with routine screening and profiling workflows